Key Segments:
By Product
-
Occlusal Splints & Night Guards
-
Medication
-
Biofeedback Therapy Devices
-
Behavioral / Cognitive Therapy
-
Surgical Interventions
By Diagnosis Type
-
Polysomnography
-
Clinical Assessment
-
Home Sleep Monitoring Devices
-
Electromyography
By Age Group
-
Adults
-
Pediatrics / Children
-
Geriatric Population
By Distribution Channel
-
Hospitals & Dental Clinics
-
Retail Pharmacies
-
Online Pharmacies
-
Rehabilitation & Therapy Centers
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America dominated with 40% revenue share in 2025, supported by advanced dental infrastructure, high awareness, insurance coverage, and widespread therapeutic adoption.
Occlusal Splints & Night Guards segment led the Sleeping Bruxism Treatment Market, favored for non-invasive, cost-effective treatment and high adoption among dental professionals and patients.
Market growth is driven by increasing prevalence of bruxism, rising stress levels, awareness of sleep disorders, and adoption of therapeutic and diagnostic solutions.
The market was valued at USD 652.14 million in 2025, supported by growing demand for oral appliances, behavioral therapies, and pharmacological interventions.
The market is expected to grow at a CAGR of 7.18% from 2026–2033, driven by rising bruxism awareness and treatment adoption globally.